TAKTAKEDA PHARMACEUTICAL CO LTD
- Market cap
- $64.66B
- as of 2026-10-23
- Latest close
- $20.24
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Drug Manufacturers - Specialty & Generic
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-04-28
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Duprey Lauren RusckowskiChief Transformation Officer | Sep 14 | Sep 15 | S | 34,535 | $18.54 | Sale −$640,279 | 191,522 | No | Form 4 |
| Plump Andrew StewartPresident, R&D | Sep 2 | Sep 3 | S | 116,191 | $18.49 | Sale −$2,148,372 | 145,465 | Yes | Form 4 |
| Plump Andrew StewartPresident, R&D | Aug 19 | Aug 21 | S | 19,651 | $18.49 | Sale −$363,347 | 261,656 | Yes | Form 4 |
| Greenway Nicola Deidre PetalChief Human Resources Officer | Aug 18 | Aug 19 | S | 12,980 | $18.11 | Sale −$235,068 | 40,049 | No | Form 4 |
| Shannon Elaine MaryPres., Global Supply & Quality | Aug 11 | Aug 12 | S | 20,363 | $17.55 | Sale −$357,371 | 67,311 | No | Form 4 |
| Greenway Nicola Deidre PetalChief Human Resources Officer | Aug 10 | Aug 12 | S | 975 | $17.50 | Sale −$17,063 | 93,431 | No | Form 4 |
| Greenway Nicola Deidre PetalChief Human Resources Officer | Aug 10 | Aug 12 | S | 33,628 | $17.51 | Sale −$588,826 | 59,803 | No | Form 4 |
| Furney Natalie Anne MarieGlobal General Counsel | Aug 10 | Aug 12 | S | 30,868 | $17.10 | Sale −$527,843 | 204,298 | No | Form 4 |
| Platford Giles RichardPresident, IBU | Aug 10 | Aug 12 | S | 31,083 | $17.10 | Sale −$531,519 | 315,838 | No | Form 4 |
| Kim Julie So-YoungPresident and CEO | Aug 10 | Aug 12 | S | 89,090 | $17.10 | Sale −$1,523,439 | 391,489 | No | Form 4 |
| Greenway Nicola Deidre PetalChief Human Resources Officer | Aug 10 | Aug 12 | S | 6,774 | $17.10 | Sale −$115,835 | 53,029 | No | Form 4 |
| Ricci GabrieleChief Data & Tech. Officer | Aug 10 | Aug 12 | S | 25,088 | $17.10 | Sale −$429,005 | 171,654 | No | Form 4 |
| Shannon Elaine MaryPres., Global Supply & Quality | Aug 10 | Aug 12 | S | 3,978 | $17.10 | Sale −$68,024 | 63,333 | No | Form 4 |
| Bitetti Teresa MariePresident, OBU | Aug 10 | Aug 12 | S | 50,012 | $17.10 | Sale −$855,205 | 252,010 | No | Form 4 |
| Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev | Aug 10 | Aug 12 | S | 22,957 | $17.10 | Sale −$392,565 | 176,977 | No | Form 4 |
| Plump Andrew StewartPresident, R&D | Aug 10 | Aug 12 | S | 165,393 | $17.10 | Sale −$2,828,220 | 766,569 | No | Form 4 |
| Duprey Lauren RusckowskiChief Transformation Officer | Aug 10 | Aug 12 | S | 47,586 | $17.10 | Sale −$813,721 | 226,057 | No | Form 4 |
| Pacheco Rhonda JanicePresident, U.S. Business Unit | Aug 10 | Aug 12 | S | 16,901 | $17.10 | Sale −$289,007 | 182,507 | No | Form 4 |
| Ibrahim Ramy Riad AhmedPresident, PDT BU | Aug 10 | Aug 12 | S | 7,277 | $17.10 | Sale −$124,437 | 102,588 | No | Form 4 |
| Farajallah Awny Samaan BotrosChief Medical Officer | Aug 10 | Aug 12 | S | 14,006 | $17.10 | Sale −$239,503 | 116,177 | No | Form 4 |
| Furuta MilanoChief Financial Officer | Jul 10 | Jul 6 | D · derivative | 16,619 | $4,931.50 | $81,956,599 | not reported | No | Form 4 |
| Miyabashira AsukaPresident, Japan Pharma B.U. | Jul 10 | Jul 6 | D · derivative | 1,022 | $4,931.40 | $5,039,891 | not reported | No | Form 4 |
| Tsusaka Miki | Jul 10 | Jul 6 | D · derivative | 2,152 | $4,931.20 | $10,611,942 | not reported | No | Form 4 |
| Iijima Masami | Jul 10 | Jul 6 | D · derivative | 2,152 | $4,931.20 | $10,611,942 | not reported | No | Form 4 |
| Reed Kimberly A. | Jul 10 | Jul 6 | D · derivative | 1,152 | $4,931.20 | $5,680,742 | not reported | No | Form 4 |
| Maraganore John | Jul 10 | Jul 6 | D · derivative | 1,152 | $4,931.20 | $5,680,742 | not reported | No | Form 4 |
| Gillis Steven | Jul 10 | Jul 6 | D · derivative | 1,152 | $4,931.20 | $5,680,742 | not reported | No | Form 4 |
| Plump Andrew StewartPresident, R&D | Jul 1 | Jul 6 | A | 125,390 | $0.00 | $0 | 931,962 | No | Form 4 |
| Kim Julie So-YoungPresident and CEO | Jul 1 | Jul 6 | A | 50,434 | $0.00 | $0 | 480,579 | No | Form 4 |
| Kim Julie So-YoungPresident and CEO | Jul 1 | Jul 6 | A | 22,800 | $0.00 | $0 | 22,800 | No | Form 4 |
| Kim Julie So-YoungPresident and CEO | Jul 1 | Jul 6 | A · derivative | 7,741 | $0.00 | $0 | 7,741 | No | Form 4 |
| Kim Julie So-YoungPresident and CEO | Jul 1 | Jul 6 | A · derivative | 7,741 | $0.00 | $0 | 7,741 | No | Form 4 |
| Kim Julie So-YoungPresident and CEO | Jul 1 | Jul 6 | A · derivative | 7,743 | $0.00 | $0 | 7,743 | No | Form 4 |
| Bitetti Teresa MariePresident, OBU | Jul 1 | Jul 6 | A | 43,886 | $0.00 | $0 | 302,022 | No | Form 4 |
| Duprey Lauren RusckowskiChief Transformation Officer | Jul 1 | Jul 6 | A | 45,140 | $0.00 | $0 | 273,643 | No | Form 4 |
| Shannon Elaine MaryPres., Global Supply & Quality | Jul 1 | Jul 6 | A | 30,094 | $0.00 | $0 | 87,674 | No | Form 4 |
| Ricci GabrieleChief Data & Tech. Officer | Jul 1 | Jul 6 | A | 37,616 | $0.00 | $0 | 196,742 | No | Form 4 |
| Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev. | Jul 1 | Jul 6 | A | 27,586 | $0.00 | $0 | 199,934 | No | Form 4 |
| Pacheco Rhonda JanicePresident, U.S. Business Unit | Jul 1 | Jul 6 | A | 50,156 | $0.00 | $0 | 199,408 | No | Form 4 |
| Furney Natalie Anne MarieGlobal General Counsel | Jul 1 | Jul 6 | A | 43,886 | $0.00 | $0 | 235,166 | No | Form 4 |
| Farajallah Awny Samaan BotrosChief Medical Officer | Jul 1 | Jul 6 | A | 17,554 | $0.00 | $0 | 130,183 | No | Form 4 |
| Greenway Nicola Deidre PetalChief Human Resources Officer | Jul 1 | Jul 6 | A | 22,570 | $0.00 | $0 | 94,406 | No | Form 4 |
| Ibrahim Ramy Riad AhmedPresident, PDT BU | Jul 1 | Jul 6 | A | 25,078 | $0.00 | $0 | 109,865 | No | Form 4 |
| Smoter Jennifer MarieChief Comm. & Gov. Officer | Jul 1 | Jul 6 | A | 18,808 | $0.00 | $0 | 18,808 | No | Form 4 |
| Platford Giles RichardPresident, IBU | Jul 1 | Jul 6 | A | 49,558 | $0.00 | $0 | 346,921 | No | Form 4 |
| Furuta MilanoChief Financial Officer | Jul 1 | Jul 6 | A | 12,300 | $0.00 | $0 | 70,200 | No | Form 4 |
| Furuta MilanoChief Financial Officer | Jul 1 | Jul 6 | A · derivative | 4,288 | $0.00 | $0 | 11,741 | No | Form 4 |
| Furuta MilanoChief Financial Officer | Jul 1 | Jul 6 | A · derivative | 4,288 | $0.00 | $0 | 8,482 | No | Form 4 |
| Furuta MilanoChief Financial Officer | Jul 1 | Jul 6 | A · derivative | 4,288 | $0.00 | $0 | 4,288 | No | Form 4 |
| Miyabashira AsukaPresident, Japan Pharma B.U. | Jul 1 | Jul 6 | A | 1,500 | $0.00 | $0 | 4,500 | No | Form 4 |
| Miyabashira AsukaPresident, Japan Pharma B.U. | Jul 1 | Jul 6 | A · derivative | 664 | $0.00 | $0 | 1,392 | No | Form 4 |
| Miyabashira AsukaPresident, Japan Pharma B.U. | Jul 1 | Jul 6 | A · derivative | 664 | $0.00 | $0 | 1,174 | No | Form 4 |
| Miyabashira AsukaPresident, Japan Pharma B.U. | Jul 1 | Jul 6 | A · derivative | 666 | $0.00 | $0 | 666 | No | Form 4 |
| Tsusaka Miki | Jul 1 | Jul 6 | A | 1,800 | $0.00 | $0 | 8,200 | No | Form 4 |
| Tsusaka Miki | Jul 1 | Jul 6 | A · derivative | 1,937 | $0.00 | $0 | 1,937 | No | Form 4 |
| Kimura Koichiro | Jul 1 | Jul 6 | A | 1,800 | $0.00 | $0 | 1,800 | No | Form 4 |
| Kimura Koichiro | Jul 1 | Jul 6 | A · derivative | 1,937 | $0.00 | $0 | 1,937 | No | Form 4 |
| Stoffels Paulus | Jul 1 | Jul 6 | A | 3,800 | $0.00 | $0 | 3,800 | No | Form 4 |
| Stoffels Paulus | Jul 1 | Jul 6 | A · derivative | 1,307 | $0.00 | $0 | 1,307 | No | Form 4 |
| Broussard Bruce D | Jul 1 | Jul 6 | A | 3,800 | $0.00 | $0 | 4,595 | No | Form 4 |
| Broussard Bruce D | Jul 1 | Jul 6 | A · derivative | 1,319 | $0.00 | $0 | 1,319 | No | Form 4 |
| Iijima Masami | Jul 1 | Jul 6 | A | 1,800 | $0.00 | $0 | 14,601 | No | Form 4 |
| Iijima Masami | Jul 1 | Jul 6 | A · derivative | 1,937 | $0.00 | $0 | 1,937 | No | Form 4 |
| Reed Kimberly A. | Jul 1 | Jul 6 | A | 3,800 | $0.00 | $0 | 10,400 | No | Form 4 |
| Reed Kimberly A. | Jul 1 | Jul 6 | A · derivative | 1,319 | $0.00 | $0 | 1,319 | No | Form 4 |
| Maraganore John | Jul 1 | Jul 6 | A | 3,800 | $0.00 | $0 | 10,400 | No | Form 4 |
| Maraganore John | Jul 1 | Jul 6 | A · derivative | 1,319 | $0.00 | $0 | 1,319 | No | Form 4 |
| Gillis Steven | Jul 1 | Jul 6 | A | 3,800 | $0.00 | $0 | 10,400 | No | Form 4 |
| Gillis Steven | Jul 1 | Jul 6 | A · derivative | 1,319 | $0.00 | $0 | 1,319 | No | Form 4 |
| Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev. | Apr 27 | Apr 28 | A | 27,740 | $0.00 | $0 | 172,348 | No | Form 4 |
| Platford Giles RichardPresident, IBU | Apr 27 | Apr 28 | A | 72,124 | $0.00 | $0 | 297,363 | No | Form 4 |
| Kim Julie So-YoungCEO - Elect | Apr 27 | Apr 28 | A | 105,416 | $0.00 | $0 | 430,145 | No | Form 4 |
| Duprey Lauren RusckowskiChief Transformation Officer | Apr 27 | Apr 28 | A | 59,990 | $0.00 | $0 | 228,503 | No | Form 4 |
| Bitetti Teresa MariePresident, OBU | Apr 27 | Apr 28 | A | 64,988 | $0.00 | $0 | 258,136 | No | Form 4 |
| Ricci GabrieleChief Data & Tech. Officer | Apr 27 | Apr 28 | A | 34,994 | $0.00 | $0 | 159,126 | No | Form 4 |
| Plump Andrew StewartPresident, R&D | Apr 27 | Apr 28 | A | 212,470 | $0.00 | $0 | 806,572 | No | Form 4 |
| Furuta MilanoChief Financial Officer | Apr 27 | Apr 28 | A | 7,800 | $0.00 | $0 | 57,900 | No | Form 4 |
| Furuta MilanoChief Financial Officer | Apr 27 | Apr 28 | A · derivative | 7,814 | $0.00 | $0 | 16,619 | No | Form 4 |
| Weber Christophe PierrePresident and CEO | Apr 27 | Apr 28 | A | 78,900 | $0.00 | $0 | 1,014,200 | No | Form 4 |
| Weber Christophe PierrePresident and CEO | Apr 27 | Apr 28 | A | 165,370 | $0.00 | $0 | 418,803 | No | Form 4 |
| Weber Christophe PierrePresident and CEO | Apr 27 | Apr 28 | A · derivative | 78,978 | $0.00 | $0 | 125,345 | No | Form 4 |